Charlotte is 23 years old and was diagnosed with Acute Myeloid Leukaemia in July 2013, she was treated at York hospital with the standard chemotherapy, she went into complete remission but the leukaemia returned within three months. She was then treated at the teenage and young adults ward at St James' hospital in Leeds with the standard chemotherapy for relapsed AML. Unfortunately this didn't work either, she was then given a different type of chemotherapy that we were told sometimes works, however it didn't. As a side effect of the chemotherapy she was left paralysed. She is suffering with peripheral neuropathy, but due to her steely determination she is regaining the use of her legs but at the moment is wheelchair bound. We were told in July 2014 that there was no further treatment available and she was referred to the Christie hospital in Manchester, who were conducting a clinical trial for relapsed AML. Whilst there we were told that Charlotte has a gene mutation AND THIS CAN BE TREATED however the treatment is not available in the UK. It is only being carried out in either Paris or New York. If treament is carried out in Paris it has to be funded by the NHS, the EU will not allow it to be funded in any other way, the treatment costs will be in the region of £70000. We applied for funding on 9th September and are awaiting a reply. This can take up to 20 working days, time which is precious and not on our side. If the funding is declined we will have no choice but to go to New York, where the costs will be much greater. We do not have an exact figure as yet but it will be significantly more than £70000 as the entire treatment needs to be fully funded. Without the treatment Charlotte will not survive, the sucess rate for the treatment is about 80%. Any monies raised in excess of what is needed will be donated to the Christie hospital who have worked tirelessly to co-ordinate this treatment. We will be posting regular updates on Charlotte's progress and how your donations are helping her fight this cruel illness.